Loading clinical trials...
Loading clinical trials...
A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study of the Safety and Neuroprotective Capacity of Scp776 in Subjects Undergoing Endovascular Thrombectomy for Acute Ischemic Stroke
Conditions
Interventions
Placebo
scp776 (1.9 mg/kg)
+3 more
Locations
22
United States
HonorHealth Scottsdale Osborn Medical Center
Scottsdale, Arizona, United States
Banner University Medical Center /Univ of Arizona
Tucson, Arizona, United States
Hartford Hospital
Hartford, Connecticut, United States
Marcus Neuroscience Institute
Boca Raton, Florida, United States
University of Miami - Jackson Memorial Hospital
Miami, Florida, United States
Augusta University Medical Center
Augusta, Georgia, United States
Start Date
October 19, 2022
Primary Completion Date
September 15, 2025
Completion Date
September 15, 2025
Last Updated
February 24, 2026
NCT07107022
NCT06692101
Lead Sponsor
Silver Creek Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions